Penny’s 19th installment in the beloved Gamache series is a particularly haunting and relevant mystery novel. Yael van der Wouden’s novel, shortlisted for this year’s Booker Prize, is about ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Wirecutter Staff The OXO Brew 9 Cup Coffee Maker is now our top-pick ...

CSL, the country’s largest pharmaceuticals group, has been forced to defend how much it is paying executives after investors delivered a so-called first strike against the remuneration plans ...

Learn More CSL Ltd (ASX: CSL) shares have lifted more than 2% into the green this past month of trade, outpacing the broader market in that time. The biotech giant held its annual general meeting ...

CSL has argued its executive pay levels are below the global median for companies in its field, after copping a first strike against its remuneration report from shareholders. The first strike ...

CSL (AU:CSL) has released an update. CSL Limited’s Annual General Meeting in Melbourne highlighted key changes in its board and provided an overview of the company’s performance in the 2024 ...

(RTTNews) - At the Annual General Meeting, Paul McKenzie, Chief Executive Officer of CSL Ltd. (CSL.AX), reaffirmed the company's financial guidance for fiscal year 2025. The company still expects ...

Here is set in one location — a piece of land in Pennsylvania — and seen through the perspective of a fixed camera over the course of more than 100 years. The relentless passage of time and ...

Carlisle Companies Inc (NYSE:CSL) achieved record third-quarter results in both EBITDA margin and earnings per share, despite challenges in the residential market and weather-related disruptions.

UT Southwestern acknowledged the settlement when reached by email, saying the review impacted "a small percentage of open positions" in the two-year timespan. "This settlement prevents additional ...

CSL has pulled studies or trials on three therapies and says US regulators have raised manufacturing concerns about a key new treatment in rare late-stage setbacks for the biotechnology giant’s ...